Skip to main content
. 2019 Jun 5;20(11):2750. doi: 10.3390/ijms20112750

Figure 2.

Figure 2

Analysis workflow for the database setup and the number of systemic chemotherapy-treated (including/excluding topotecan) patients at each PFS-cutoff.